Your browser is no longer supported. Please, upgrade your browser.
TWST Twist Bioscience Corporation daily Stock Chart
TWST [NASD]
Twist Bioscience Corporation
Index- P/E- EPS (ttm)-3.99 Insider Own7.50% Shs Outstand32.19M Perf Week7.03%
Market Cap852.39M Forward P/E- EPS next Y-2.18 Insider Trans- Shs Float26.76M Perf Month22.08%
Income-107.70M PEG- EPS next Q-0.83 Inst Own60.80% Short Float13.43% Perf Quarter-12.52%
Sales54.40M P/S15.67 EPS this Y-20.10% Inst Trans12.55% Short Ratio16.06 Perf Half Y4.05%
Book/sh5.81 P/B4.56 EPS next Y34.50% ROA-54.80% Target Price32.67 Perf Year20.15%
Cash/sh5.03 P/C5.27 EPS next 5Y- ROE-150.40% 52W Range13.99 - 35.95 Perf YTD14.68%
Dividend- P/FCF- EPS past 5Y- ROI-71.20% 52W High-26.34% Beta-
Dividend %- Quick Ratio7.00 Sales past 5Y- Gross Margin12.80% 52W Low89.28% ATR1.44
Employees289 Current Ratio7.20 Sales Q/Q109.20% Oper. Margin- RSI (14)67.63 Volatility7.50% 5.65%
OptionableYes Debt/Eq0.05 EPS Q/Q-39.20% Profit Margin- Rel Volume1.82 Prev Close26.18
ShortableYes LT Debt/Eq0.03 EarningsDec 11 AMC Payout- Avg Volume223.83K Price26.48
Recom2.00 SMA2013.37% SMA5013.69% SMA2001.89% Volume406,601 Change1.15%
May-31-19Initiated Evercore ISI Outperform
Nov-26-18Initiated JP Morgan Neutral $27
Dec-12-19 07:38AM  The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win Benzinga
Dec-11-19 04:05PM  Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results Business Wire
08:00AM  Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration Business Wire
Nov-22-19 08:24AM  If You Had Bought Twist Bioscience (NASDAQ:TWST) Stock A Year Ago, You'd Be Sitting On A 13% Loss, Today Simply Wall St.
Nov-20-19 08:01AM  Twist Bioscience to Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on Wednesday, December 11, 2019 Business Wire +5.35%
08:00AM  Twist Bioscience Promotes Patrick J. Finn, Ph.D., to Chief Commercial Officer Business Wire
Nov-13-19 08:00AM  Twist Bioscience to Present at Upcoming Investor Conferences Business Wire
Nov-08-19 08:00AM  Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery Business Wire
Oct-30-19 08:00AM  Twist Bioscience to Provide Target Enrichment Products for MGI in Europe and Asia Pacific Business Wire
Oct-28-19 02:15PM  Hedge Funds Have Never Been This Bullish On Twist Bioscience Corporation (TWST) Insider Monkey
Oct-25-19 08:00AM  Twist Bioscience Appoints Seasoned Life Sciences Industry Executive Nicolas M. Barthelemy to Board of Directors Business Wire
Oct-24-19 02:01PM  Praesens Foundation, Institut Pasteur, Institut Pasteur de Dakar, University of Nebraska Medical Center, Twist Bioscience Consortium Win Prix Galien MedStartUp Award Business Wire
Oct-16-19 08:00AM  Twist Bioscience Showcases Next-Generation Sequencing Products and Results at American Society for Human Genetics 2019 Annual Meeting Business Wire
Oct-01-19 08:00AM  Twist Bioscience Showcases New Innovation Lab at SynBioBeta 2019 Business Wire -5.40%
Sep-24-19 08:00AM  Twist Bioscience to Present at SynBioBeta 2019 Business Wire
Aug-30-19 08:00AM  Twist Bioscience to Present at Two Investor Conferences in September Business Wire
Aug-28-19 08:15PM  Twist Bioscience Corp (TWST) COO William Banyai Sold $614,240 of Shares GuruFocus.com +5.44%
Aug-19-19 07:14PM  Twist Bioscience Grows Q3 Revenue 108%, but Losses Pile Up Motley Fool
Aug-02-19 07:43PM  Twist Bioscience Corporation (TWST) Q2 2019 Earnings Call Transcript Motley Fool -7.68%
Aug-01-19 04:05PM  Twist Bioscience Reports Third Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress Business Wire
Jul-29-19 08:00AM  Twist Bioscience Launches Long Oligos to Fuel Drug Development, DNA Data Storage and Gene Editing Research Business Wire
Jul-25-19 08:01AM  Twist Bioscience Enhances DNA Storage Capabilities Through Agreement With Imagene SA Business Wire
08:00AM  Twist Bioscience to Report Fiscal 2019 Third Quarter Financial Results on Thursday, August 1, 2019 Business Wire
Jun-17-19 08:00AM  Twist Bioscience Launches Mouse Exome to Power Genetic Research Business Wire
May-28-19 08:00AM  Twist Bioscience to Present at the Jefferies 2019 Global Healthcare Conference Business Wire
May-23-19 08:00AM  Twist Bioscience Strengthens Board With Semiconductor and Storage Expert Nelson C. Chan Business Wire
08:00AM  Collaboration of Four Biotech Companies Showcases High Throughput DNA Assembly Platform for Diverse Applications Business Wire
May-16-19 08:00AM  Twist Bioscience to Present at the UBS Global Healthcare Conference Business Wire
May-14-19 08:41AM  Twist Bioscience (TWST) Catches Eye: Stock Jumps 8% Zacks
May-13-19 11:55AM  Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire +7.97%
May-08-19 08:03PM  Twist Bioscience Announces Pricing of $78.8 Million Public Offering of Common Stock Business Wire
May-06-19 04:10PM  Twist Bioscience Announces Proposed Public Offering of Common Stock Business Wire
May-02-19 07:00AM  Twist Bioscience Delivers Steep Loss in Fiscal Q2 2019 Motley Fool
Apr-30-19 07:45PM  Twist Bioscience Corporation (TWST) Q2 2019 Earnings Call Transcript Motley Fool -14.71%
06:22PM  Twist Bioscience: Fiscal 2Q Earnings Snapshot Associated Press
04:05PM  Twist Bioscience Reports Second Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress Business Wire
Apr-25-19 08:00AM  Twist Bioscience Announces Synthetic DNA Biosecurity Publication in Frontiers Business Wire
Apr-18-19 08:00AM  Twist Bioscience to Report Fiscal 2019 Second Quarter Financial Results on Tuesday, April 30, 2019 Business Wire
Apr-15-19 08:00AM  Twist Bioscience and iGEM Partner to Provide Synthetic DNA for iGEM Competition and Registry Business Wire
Apr-11-19 08:00AM  Twist Bioscience Announces Antibody Optimization Agreement with Pandion Therapeutics Business Wire
Apr-10-19 08:43AM  Twist Bioscience (TWST) Looks Good: Stock Adds 6.5% in Session Zacks
Apr-09-19 08:01AM  Twist Bioscience Customized Libraries for Biologics Discovery Highlighted at PEGS Boston 2019 Business Wire +6.49%
08:00AM  Twist Bioscience Adopts Battelles ThreatSEQ DNA Screening Web Service for Advanced Biosecurity Business Wire
Apr-04-19 08:00AM  Twist Bioscience and LakePharma Form Strategic Collaboration to Provide Antibody Discovery and Development Services Business Wire -5.21%
Apr-01-19 08:00AM  Twist Bioscience Announces Presentations and User Group Meeting at PEGS Boston 2019 Business Wire
Mar-05-19 08:00AM  Twist Bioscience to Present at Cowen 39th Annual Healthcare Conference Business Wire
Feb-28-19 01:45PM  Twist Bioscience Showcases Next-Generation Sequencing Solutions at the 2019 Advances in Genome Biology and Technology Meeting Business Wire
Feb-07-19 06:03PM  Twist Bioscience: Fiscal 1Q Earnings Snapshot Associated Press
04:05PM  Twist Bioscience Reports First Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress Business Wire
04:04PM  Twist Bioscience Announces Appointment of Martin Kunz as Senior Vice President, Operations Business Wire
Jan-30-19 08:00AM  Twist Bioscience Chief Technology Officer Presented at Praesens Foundation Future Health Threats Initiative 2019 Business Wire
Jan-29-19 09:38AM  What's next for this slow-moving Peninsula biotech IPO? American City Business Journals
Jan-28-19 08:00AM  Twist Bioscience to Report Fiscal 2019 First Quarter Financial Results on Thursday, February 7, 2019 Business Wire
Jan-23-19 08:00AM  Twist Bioscience Receives ISO 13485:2016 and 9001:2015 Certifications of its Quality Management Systems for NGS Target Enrichment Panels Business Wire
Jan-11-19 02:05PM  8 of the 10 biggest Q4 startup exits in Bay Area came from IPOs in October American City Business Journals -5.12%
Jan-09-19 09:09AM  Government shutdown may mean an IPO-less January American City Business Journals
Jan-07-19 08:00AM  Twist Bioscience Enhances Genes Product Offering with Longer Genes and Offers Access to Its Application Programming Interface Business Wire
Jan-02-19 08:00AM  Twist Bioscience to Present at the 37th Annual J.P. Morgan Healthcare Conference Business Wire +5.93%
Dec-20-18 09:48PM  Twist Bioscience Corp (TWST) Files 10-K for the Fiscal Year Ended on September 30, 2018 GuruFocus.com -11.21%
Dec-19-18 04:05PM  Twist Bioscience Reports Fiscal 2018 Fourth Quarter and Full Year Financial Results and Highlights Commercial and Operational Progress Business Wire
Dec-10-18 10:58AM  Here's Why Twist Bioscience Stock Soared 89% in November Motley Fool -15.94%
Dec-05-18 08:00AM  Twist Bioscience to Report Fiscal 2018 Fourth Quarter and Full Year Financial Results on Wednesday, December 19, 2018 Business Wire
Nov-27-18 08:00AM  Twist Bioscience to Present at the Evercore ISI HealthCONx Conference Business Wire -9.29%
Nov-26-18 02:03PM  Here's how much better insiders have profited from this year's IPO boom American City Business Journals
08:00AM  Twist Bioscience Appoints Experienced Technology Executive Jan Johannessen to Board of Directors Business Wire
Oct-31-18 02:45PM  Twist Bioscience Corporation Announces Pricing of Initial Public Offering Business Wire
Oct-28-18 10:53AM  IPO Outlook For The Week: Banks And Biotechs Benzinga
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. Twist Bioscience Corporation has a collaboration agreement with Pandion Therapeutics, Inc. to apply its antibody optimization platform for a targeting arm of a bispecific antibody. The company was founded in 2013 and is headquartered in San Francisco, California.